Cart
sales@molnova.com
Nimucitinib
CAS No. 2740557-24-6
Nimucitinib( —— )
Catalog No. M36068 CAS No. 2740557-24-6
Nimucitinib is a Janus kinase (JAK) inhibitor that can be used to treat dry eye and promote tear production.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 135 | In Stock |
|
| 5MG | 227 | In Stock |
|
| 10MG | 353 | In Stock |
|
| 25MG | 654 | In Stock |
|
| 50MG | 918 | In Stock |
|
| 100MG | 1423 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2762 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNimucitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionNimucitinib is a Janus kinase (JAK) inhibitor that can be used to treat dry eye and promote tear production.
-
DescriptionNimucitinib is a Janus kinase (JAK) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2740557-24-6
-
Formula Weight480.51
-
Molecular FormulaC25H26F2N6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (260.14 mM; Ultrasonic )
-
SMILESN(CC1=CC(F)=CC(F)=C1)C=2C(C(N)=O)=CN=C(NC3=CC(NC(=O)[C@H]4CCCNC4)=CC=C3)C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. WHO Drug Information, Vol. 36, No. 4, 2022.
molnova catalog
related products
-
Cetylpyridinium Chlo...
Cetylpyridinium chloride is a cationic quaternary ammonium compound used as oropharyngeal antiseptic.
-
SHR0302
SHR0302 is a JAK inhibitor that binds JAK1 with stronger affinity than others (Selectivity for JAK1 is more than 10 times for JAK2, 77 times for JAK3, 420 times for Tyk2).
-
WP1066
WP1066 is a novel inhibitor of JAK2 and STAT3 with IC50 of 2.30 μM and 2.43 μM in HEL cells.
